https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/accounts-payable https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/accounts-receivable https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/aoci https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/assets-noncurrent https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/basic-shares https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/capital-expenditures https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/cash-and-equivalents https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/cash-flow-breakdown https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/common-stock-value https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/comprehensive-income https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/cost-of-goods-sold https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/current-assets https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/current-liabilities https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/customer-advances-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/deferred-costs https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/deferred-costs-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/derivative-loss-on-derivative https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/diluted-shares https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/dividends-declared https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/due-from-related-parties-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/due-from-related-parties-noncurrent https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/due-to-related-parties-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/eps https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/eps-basic https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/financing-cash-flow https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/form-d-other https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/gain-on-derivative-instruments-pretax https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/general-and-administrative-expense https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/gross-profit https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/income-tax https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/income-taxes-paid https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-accounts-receivable-related-parties https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-customer-advances https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-due-from-related-parties-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-notes-payable-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-notes-receivable-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/insider-transactions-other https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/insider-transactions-warrants https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/interest-expense https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/interest-paid https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/inventory https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/investing-cash-flow https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/investment-income-interest https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/liabilities-noncurrent https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/loans-payable-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/net-change-in-cash https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/net-income https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/notes-and-loans-receivable-net-noncurrent https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/notes-payable-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/operating-cash-flow https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/operating-income https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/other-receivables-net-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/prepaid-expense-current https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/proceeds-from-contributed-capital https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/proceeds-from-other-debt https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/proceeds-from-repayments-of-restricted-cash-financing-activities https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/proceeds-from-repayments-of-short-term-debt https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/proceeds-from-sale-of-notes-receivable https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/property-plant-equipment https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/public-float https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/retained-earnings https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/retained-earnings-appropriated https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/retained-earnings-unappropriated https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/revenue https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/selling-expense https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/shareholders-equity https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/shares-authorized https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/shares-issued https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/short-term-borrowings https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/stock-based-compensation https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/stockholders-equity-other https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/total-assets https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/total-liabilities https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/first-china-pharmaceutical-group-inc/treasury-stock-value